What’s the matter? Natco Pharma has gone to the Delhi High Court to challenge the Indian Patent Office’s decision to grant Novartis a second patent for its breast cancer drug… Continue Reading
Noel Tata’s New Vision: Building Hospitals That Last, Not Just Projects That End
Tata Trusts Chairman Noel Tata recently shared a simple but powerful idea: instead of just funding health projects here and there, the Trusts now want to build lasting institutions, hospitals,… Continue Reading
India Approves Qdenga, Its First Dengue Vaccine. What You Need to Know
India has taken a major step in the fight against dengue. The Drug Controller General of India (DCGI) has granted marketing authorisation to Qdenga, developed by Japan’s Takeda, making it… Continue Reading
Medicines With Over 12% Alcohol Now Need a Prescription: What This Means
If you’ve bought a cough syrup or health tonic off the shelf before, that’s about to change for certain products. Here’s what’s happening. What exactly changed? The Ministry of Health… Continue Reading
A pill in your pocket: Lilly’s Foundayo wins FDA approval but who actually benefits?
On April 1, 2026, the U.S. Food and Drug Administration approved Foundayo (orforglipron) — Eli Lilly’s once-daily oral pill for obesity. The approval came in a record-breaking 50 days, the fastest for any… Continue Reading